Video-Tumorboard PLUS
NCT06980740 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-05-20
Summary
In weekly expert meetings for oncological diagnostics and therapy, known as tumor boards, individual therapy recommendations are developed for cancer patients. By further developing and optimizing the CCCs' video tumor boards, initially using skin cancer as an example, we want to ensure that more patients can benefit from the expertise of several specialist disciplines and innovations - regardless of where they live.
Conditions
- Malignant Melanoma
- Telemedicine
Sponsors & Collaborators
-
Deutsche Krebshilfe e.V., Bonn (Germany)
collaborator OTHER -
University Hospital, Bonn
collaborator OTHER -
University Hospital Dresden
collaborator OTHER -
University Hospital Muenster
lead OTHER
Principal Investigators
-
Philipp Lenz, MD · Westdeutsches Tumorzentrum Münster, Universitätsklinikum Münster
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-01
- Primary Completion
- 2026-05-31
- Completion
- 2027-05-31
Countries
- Germany
Study Locations
More Related Trials
-
Safety and Avoidance of Futile Excisions Through Skin Tele-triage
NCT05982600 ·Status: COMPLETED
-
AI-Augmented Skin Cancer Diagnosis in Teledermatoscopy
NCT06080711 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
NCT03137511 ·Status: COMPLETED ·Phase: NA
-
Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults
NCT06621810 ·Status: RECRUITING
-
One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491 ·Status: ACTIVE_NOT_RECRUITING
-
Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
NCT04385732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fast Track Diagnosis of Skin Cancer by Advanced Imaging
NCT04229277 ·Status: COMPLETED ·Phase: NA
-
Melanoma Detection in Switzerland With VECTRA
NCT04605822 ·Status: COMPLETED
-
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
NCT04389112 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases
NCT00264056 ·Status: UNKNOWN ·Phase: NA
-
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
NCT06999499 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Community Based Strategies for Early Detection of Melanoma
NCT04799106 ·Status: UNKNOWN
-
Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
NCT03581188 ·Status: COMPLETED ·Phase: NA
-
Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)
NCT02434107 ·Status: COMPLETED ·Phase: NA
-
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
NCT01482104 ·Status: COMPLETED ·Phase: NA
-
Nevus Doctor Clinical Decision Support for GPs
NCT03246412 ·Status: COMPLETED ·Phase: NA
-
Reflectance Confocal Microscopy to Diagnose MM & LM
NCT03508297 ·Status: COMPLETED
-
In-vivo Optical Coherence Tomography Imaging in Dermatooncology
NCT01680562 ·Status: UNKNOWN
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
NCT01491711 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
NCT02902029 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Obstructive SAS on Metastatic Potential of Cutaneous Melanoma
NCT02699918 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Head and Neck Melanoma; Access to Staging and Surgical Treatment
NCT05900102 ·Status: COMPLETED
-
Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management
NCT04789421 ·Status: COMPLETED ·Phase: NA